Be more than happy to take the whistleblower complaints to the public. Might have grabbed his communications i was able to navigate quicker than most and that is the key thing. It doesnt take everyone to do the same thing. Some people might be comfortable just going through the ig and the sun it covetable going to the representative or senator and some light be comfortable going to the press. But there are different levels. You dont have to go as far as we did. In some cases there is an exception that there are different ways that you can get the information out and different people that want to. Theres the civil groups, Veterans Service organizations that would be more than happy to get the information they have direct connections with other leaders in congress. There are different ways that i would tell you this. You feel better when you Say Something versus holding it in. I have no doubt there are employees listening tonight and seeing the comments and i might add that they are prob
Is the way i look at it. The lines are drawn. I thought of that last night. You know, the lines are drawn, the winners and losers are clear. If you two this way, here are the party who is go Everybody Knows what everybody else is going to say. Its all been laid out. And this is reminding me of what it was like in 1995 in cyber law when that was not true. And this is a real opportunity. Its a fabulous opportunity. Just as it was in 19 t 5, youre behind the vail of ignorance. So you can think about rule making and law without the winners and the losers piling in and fighting over it purely as a sort of economic battle ground. It is about the ideas. And it is about the issue. And i think thats what hes talking about. He wants to take that energy here. I dont think cyber law structure is the right one. I think cyber law process is the right one. He talks about interdisciplinary prague mattism. The attention to metaphor. Its ault about how people were thinking about it that could be transpl
The United States occupies a leadership position in clinical advancements, in terms of pharmaceuticals, medical devices, innovative care processes and interventional techniques.
Merck to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024 itnewsonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnewsonline.com Daily Mail and Mail on Sunday newspapers.
First-in-human data for potential first-in-class anti-CEACAM5 ADC with topoisomerase 1 inhibitor payload, M9140, in treatment of metastatic colorectal cancer to be featured in oral presentation